Vaccination does not reduce transmission!

The studies submitted to the EMA say nothing about transmission

First, let us check the commissioner’s first claim concerning the pharmaceutical companies’ studies submitted to the EMA on transmission.

To do so, let us go to the EMA website.
There we see:

For the Pfizer vaccine (Comirnaty)

Source: https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty

For Moderna (Spikevax):

Source: https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax

For AstraZeneca (renamed Vaxzevria):

Source: https://www.ema.europa.eu/

For Johnson&Johnson (Vaccine Janssen):

Source: https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen

So to the question “Can the COVID-19 vaccine reduce transmission of the virus from one person to another?”, the answer is the same for the 4 vaccines currently on the market: “The effect of the COVID-19 vaccine on the spread of the SARS-CoV-2 virus in the community is not yet known. It is not yet known how much vaccinated people may still be able to carry and spread the virus.”

The answer is therefore unequivocal: the studies submitted by the pharmaceutical companies to the EMA have never demonstrated any reduction in transmission.

The first observational studies show a 40 to 50% reduction in transmission

It must be acknowledged that some of the studies submitted to the EMA were carried out more than a year ago. Since then, a large number of people have been vaccinated around the world, and studies therefore allow us to know a little more about the subject.

In the United Kingdom, a study carried out between 4 January and 28 February 2021 (a period when the Alpha variant was beginning to spread there) shows a 40 to 50% reduction in transmission.
Source: https://pubmed.ncbi.nlm.nih.gov/34161702/

In Belgium, the GEMS report of 19/05/2021 states on page 45:

“On the basis of the results of contact tracing in Belgium between 01/02/2021 and 04/05/2021, it is possible to determine the protection offered by a vaccine against a positive test. As a reference, the ‘secondary attack rate’ after a high-risk contact between unvaccinated people is used: the risk of a secondary infection in an unvaccinated person who has been in contact with a vaccinated index case is only half the risk of secondary infections after contact with an unvaccinated index case. Vaccinated people are therefore less contagious”.

So according to the GEMS, vaccination supposedly reduces infections by 50%.

The vaccine no longer shows any effectiveness on transmission with the Delta variant

Since these various studies, the Delta variant has become dominant. And one has to admit that the news is not encouraging as far as transmission is concerned.

In early September, 49 vaccinated senior citizens go by coach to the North Sea. On their return, 32 are infected (65%).
Source: https://lanouvellegazette.sudinfo.be/

A study carried out in California over a two-month period from 17 June to 31 August 2021 confirms that the vaccine no longer offers any advantage on transmission.

“We found no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta.”
Source: https://www.medrxiv.org/content/10.1101/2021.09.28.21264262v1

An official study of 30 September on the COVID situation issued by the UK Health Security Agency, which is the English Sciensano, shows that 80% of infections linked to a known vaccination status in people over 18 were found in vaccinated people. This while less than 80% of the population over 18 is vaccinated. Looking in detail, we see that while vaccination still seems to offer a slight advantage on transmission for the under-40s, it tends, on the contrary, to favour infections for the over-40s.

Source: https://assets.publishing.service.gov.uk/government/

It is therefore clear that the vaccine no longer offers a significant advantage on transmission against the Delta variant.

Let us hope that our politicians, commissioners and experts will be able to adapt their strategy in the light of this information. Basing weighty decisions on erroneous assumptions or outdated studies will not achieve the intended objective and will only lead to disappointment, incomprehension and mistrust.

By BAM!-DETOX